SELLAS Life Sciences Group Stock Price Drops 7.7%

Got story updates? Submit your updates here. ›

Shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) traded down 7.7% during mid-day trading on Monday, with the stock closing at $4.0250 per share. The company's stock price has seen significant volatility in recent months.

Why it matters

SELLAS Life Sciences Group is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies, making its stock performance an important indicator of investor sentiment in the biotech sector.

The details

The drop in SELLAS' stock price came on a day of broader market volatility, with the company's shares trading as low as $4.04 during the session. Trading volume was down 60% from the average, suggesting lower investor activity. Several analysts have weighed in on the stock, with Maxim Group recently lifting its price target to $10 while Weiss Ratings maintained a 'sell' rating.

• SELLAS Life Sciences Group's stock closed at $4.36 on the previous trading day.
• The company's shares traded as low as $4.04 and last traded at $4.0250 on Monday.

What’s next

Investors will be closely watching SELLAS Life Sciences Group's upcoming earnings report and any further analyst commentary on the stock's performance and outlook.